92 results on '"Ylikorkala, Olavi"'
Search Results
2. The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study
3. Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland
4. Effect of hot flushes on cardiovascular autonomic responsiveness: A randomized controlled trial on hormone therapy
5. Use of estradiol–progestin therapy associates with increased risk for uterine sarcomas
6. Cardiovascular autonomic responsiveness in postmenopausal women with and without hot flushes
7. Association between high risk papillomavirus DNA and nitric oxide release in the human uterine cervix
8. Soy–tibolone combination—Effect on lipids in postmenopausal monkeys and women
9. Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation
10. Effect of oral and transdermal hormone therapy on hyaluronic acid in women with and without a history of intrahepatic cholestasis of pregnancy
11. Benefits and risks of long-term low-dose oral continuous combined hormone therapy
12. Misoprostol induces cervical nitric oxide release in pregnant, but not in nonpregnant, women
13. Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women
14. Is there any link between insulin resistance and inflammation in established preeclampsia?
15. Changes in bone mineral density during and after 3 years’ use of tamoxifen or toremifene
16. HRT as secondary prevention of cardiovascular disease
17. Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone–binding globulin in osteoporotic women
18. Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women
19. Nitric oxide metabolites in cervical fluid during pregnancy: Further evidence for the role of cervical nitric oxide in cervical ripening
20. Susceptibility Loci for Preeclampsia on Chromosomes 2p25 and 9p13 in Finnish Families
21. National differences in lipid response to postmenopausal hormone replacement therapy
22. Pulmonary prostacyclin is associated with less severe respiratory distress in preterm infants
23. A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy
24. CA 125 and follicle stimulation: Reply of the authors
25. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women
26. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia
27. Effect of an in vitro fertilization program on serum CA 125, tumor-associated trypsin inhibitor, free β-subunit of human chorionic gonadotropin, and common α-subunit of glycoprotein hormones
28. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels
29. Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine
30. Effects on serum lipid profiles of continuous 17β-estradiol, intermittent norgestimate regimens versus continuous combined 17β-estradiol/ norethisterone acetate hormone replacement therapy
31. Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients
32. Leptin during and after preeclamptic or normal pregnancy: Its relation to serum insulin and insulin sensitivity
33. Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells
34. Evidence of a state of increased insulin resistance in preeclampsia
35. Effects of transdermal nitroglycerin on impedance to flow in the uterine, umbilical, and fetal middle cerebral arteries in pregnancies complicated by preeclampsia and intrauterine growth retardation
36. Estrogen and postmenopausal estrogen/progestin therapy: effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production
37. The Long-Term Effects of Oral and Transdermal Postmenopausal Hormone Replacement Therapy on Nitric Oxide, Endothelin-1, Prostacyclin, and Thromboxane
38. Evidence of interplay between plasma endothelin-1 and 17β-estradiol in regulation of uterine blood flow and endometrial growth in infertile women
39. Antibodies to β2-glycoprotein I and prothrombin in habitual abortion
40. Effect of antiestrogen regimen on prostacyclin and thromboxane A2 in postmenopausal patients with breast cancer: Evidence of significance of hypertension, smoking or previous use of estrogen therapy
41. Hormone replacement therapy modifies the capacity of plasma and serum to regulate prostacyclin and endothelin-1 production in human vascular endothelial cells
42. The calcium-dependent nitric oxide production of human vascular endothelial cells in preeclampsia
43. Hirudin stimulates prostacyclin but not endothelin-1 production in cultured human vascular endothelial cells
44. Antibodies to oxidized low-density lipoprotein and to cardiolipin in nonpregnant and pregnant women with habitual abortion
45. Reply
46. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor
47. Coitus during pregnancy is not related to bacterial vaginosis or preterm birth
48. Mechanisms of vascular protection by hormonal replacement therapy
49. Human serum, plasma, and platelets stimulate prostacyclin and endothelin-1 synthesis in human vascular endothelial cells
50. 7 The role of prostaglandins in obstetrical disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.